Delivery Order SPE2DB24D2106-SPE2DB25FAVNX
Award Date
6/13/25
Potential Completion Date
6/16/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,070.16, is for the delivery of 4,567,197,276 units of the prescription drug Lisdexamfetamine 20 mg capsules. The award has a completion date of February 7, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,367.72, is for the delivery of 4,567,997,741 units of the prescription drug lisdexamfetamine 20 mg capsules. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 held by DMS Pharmaceutical Group with the DLA, which enables the agency to issue delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,070.16 firm fixed-price contract is for the delivery of 100 units of 40 mg lisdexamfetamine capsules. The contract has an ultimate completion date of March 20, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,000.98 contract is for the delivery of 4,567,329,296 lisdexamfetamine 20 mg capsules, and has an ultimate completion date of February 21, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a federal contract award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order valued at $1,176.64 for the supply of 4567764395 Lisdexamfetamine 50 mg capsules. The contract has a firm fixed-price pricing type and an ultimate completion date of April 2, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,135.88 award is for the delivery of 100 units of 30mg lisdexamfetamine capsules. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which allows the agency to issue delivery orders for a wide range of pharmaceutical products,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,501.38, is for the delivery of lisdexamfetamine 20 mg capsules. The award is not designated as a set-aside contract. The contract has an ultimate completion date of March 12, 2025 and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,172,467 units of the prescription medication Lisdexamfetamine 30 mg Capsules, with a total ceiling value of $2,731.28. The contract has an ultimate completion date of May 8, 2025 and was awarded on May 7, 2025. This delivery order is part of a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lisdexamfetamine 40 mg capsules, a prescription medication, with a ceiling value of $1,491.52 and a performance period ending on June 6, 2025. The contract is a firm-fixed price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of VYVANSE 40 MG CAPSULE 100S, with a ceiling value of $1,719.31 and a performance period ending on May 29, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in providing a range of pharmaceutical products, including branded and generic...